fluoxetine and tv3326

fluoxetine has been researched along with tv3326 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V	1
Feng, F; He, S; Jiang, H; Jiang, X; Liu, W; Qu, W; Sun, H; Zhou, J	1

Reviews

2 review(s) available for fluoxetine and tv3326

Article	Year
Multi-target-directed ligands to combat neurodegenerative diseases. Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid	2008
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. Journal of medicinal chemistry, 2019, 10-24, Volume: 62, Issue:20 Topics: Animals; Drug Combinations; Drug Delivery Systems; Drug Design; Humans; Ligands	2019

Article

Year

Multi-target-directed ligands to combat neurodegenerative diseases.

Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3

Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid

2008

Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms.

Journal of medicinal chemistry, 2019, 10-24, Volume: 62, Issue:20

Topics: Animals; Drug Combinations; Drug Delivery Systems; Drug Design; Humans; Ligands

2019